Sirolimus immunosuppression for graft-versus-host disease prophylaxis and therapy: an update
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Hematology
Reference28 articles.
1. SIROLIMUS (RAPAMYCIN) FOR THE TREATMENT OF STEROID-REFRACTORY ACUTE GRAFT-VERSUS-HOST DISEASE1
2. Rapamycin for Refractory Acute Graft-Versus-Host Disease
3. Sirolimus as Primary Treatment of Acute Graft-versus-Host Disease following Allogeneic Hematopoietic Cell Transplantation
4. Sirolimus as Part of Immunosuppressive Therapy for Refractory Chronic Graft-versus-Host Disease
5. Sirolimus in combination with tacrolimus and corticosteroids for the treatment of resistant chronic graft-versus-host disease
Cited by 40 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Nanoscale metal-organic framework delivers rapamycin to induce tissue immunogenic cell death and potentiates cancer immunotherapy;Nanomedicine: Nanotechnology, Biology and Medicine;2023-06
2. HLA-haploidentical hematopoietic stem cells transplantation with regulatory and conventional T-cell adoptive immunotherapy in pediatric patients with very high-risk acute leukemia;Bone Marrow Transplantation;2023-02-11
3. Rapamycin limits CD4+ T cell proliferation in simian immunodeficiency virus–infected rhesus macaques on antiretroviral therapy;Journal of Clinical Investigation;2022-05-16
4. T-Cell Metabolism in Graft Versus Host Disease;Frontiers in Immunology;2021-10-29
5. Delayed introduction of sirolimus in paediatric intestinal transplant recipients: indications and long‐term benefits;Transplant International;2021-09-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3